Further exploration of the role of adiponectin in the pathophysiology of diseases, including RA, and its mechanisms of action may provide a tool for developing personalized therapeutic approaches based on modulating the activity of individual adiponectin multimers. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.